Meet our new state regulatory affairs director
Sarah Derr, PharmD, MPS, joined the APC staff this week. She is former Minnesota Pharmacists Association executive director and CEO.
Being an exceptional compounding professional means you never stop learning
We advocate for compounding pharmacies and facilities on a range of state and federal issues affecting patient access to compounded medications. We represent pharmacists and technicians in both traditional 503A compounding pharmacies and 503B outsourcing facilities, as well as prescribers, patients, educators, and suppliers. We’re 5,000 members strong and growing.
Sarah Derr, PharmD, MPS, joined the APC staff this week. She is former Minnesota Pharmacists Association executive director and CEO.
FDA issued a safety communication following adverse events associated with compounded IV glutathione made with dietary supplement-grade glutathione.
FDA has named Clint Narver as the permanent director of the Office of Compounding Quality and Compliance. Edisa Gozun, PharmD, will serve as deputy ...
Compounders on Capitol Hill runs September 14 – 16, and if you want your Hill visits guaranteed, you need to sign up by September 1.
The beginning of the calendar year is the best time to be grab a package deal.
Unapproved obesity drug spawns a black market frenzy
CNN: The future of peptides in the US is about to become clearer. Here’s what you should know
Endpoints News: Updated: FDA adcomm backs popular wellness peptides, despite staff concerns
Medscape: FDA Expert Panel Backs Compounding of Six Peptides
Washington Post: Peptide boom has states scrambling to protect consumers, Post investigation finds